New Pancreatic Cancer Treatment May Add Years to the Lives of Those Facing Death

Last year, a 74-year old woman was diagnosed with inoperable pancreatic cancer. Her family turned to Miami Cancer Institute in their search for treatment options. Since her diagnosis, she became part of the TIGeR-PaC clinical trial, and is now in a maintenance phase and says her quality of life has improved.

View the entire article on the Miami Herald

RenovoRx is participating in clinical trials and the FDA has not determined the safety and or efficacy of its clinical drug development program.